DNA Topoisomerases as Anticancer Drug Targets
- 1 January 1990
- book chapter
- Published by Elsevier
- Vol. 21, 149-183
- https://doi.org/10.1016/s1054-3589(08)60342-7
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Topoisomerase II: A potential target for novel antifungal agentsBiochemical and Biophysical Research Communications, 1989
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugsBiochemical and Biophysical Research Communications, 1987
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- Topoisomerase II cleavage in chromatinJournal of Molecular Biology, 1986
- Death and the cellImmunology Today, 1986
- Metaphase chromosome structureJournal of Molecular Biology, 1986
- Isolation of a mitochondrial DNA topoisomerase from human leukemia cellsBiochemical and Biophysical Research Communications, 1984
- Studies on camptothecin-induced degradation and apparent reaggregation of DNA from L1210 cellsBiochemical and Biophysical Research Communications, 1972
- Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coliBiochemical and Biophysical Research Communications, 1970